Calendar
December 14, 2023 - DNB Nordic Healthcare Conference
December 19, 2023 - Egetis Investor Day
February 22, 2024 - Year-end Report Q4 2023
May 3, 2024 - Interim Report Q1 2024
May 6, 2024 - Annual General Meeting
Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com
